These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17761404)

  • 1. Platelet monoamine oxidase activity in obsessive-compulsive disorder.
    Arrojo M; Baca-Garcia E; Perez-Rodriguez MM; Dolengevich-Segal H; Navio-Acosta M; Rodriguez-Salgado B; Saiz-Ruiz J
    Eur Psychiatry; 2007 Nov; 22(8):525-9. PubMed ID: 17761404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopathology and personality characteristics in relation to blood serotonin in Tourette's syndrome and obsessive-compulsive disorder.
    Cath DC; Spinhoven P; Landman AD; van Kempen GM
    J Psychopharmacol; 2001 Jun; 15(2):111-9. PubMed ID: 11448084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet serotonergic markers and aggressive behaviour in healthy subjects.
    Castrogiovanni P; Capone MR; Maremmani I; Marazziti D
    Neuropsychobiology; 1994; 29(3):105-7. PubMed ID: 8022528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A longitudinal event-related potential study of selective serotonin reuptake inhibitor therapy in treatment-naïve pediatric obsessive compulsive disorder patients.
    Yamamuro K; Ota T; Iida J; Kishimoto N; Nakanishi Y; Matsuura H; Uratani M; Okazaki K; Kishimoto T
    Psychiatry Res; 2016 Nov; 245():217-223. PubMed ID: 27552672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
    Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
    J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder.
    Flament MF; Rapoport JL; Murphy DL; Berg CJ; Lake CR
    Arch Gen Psychiatry; 1987 Mar; 44(3):219-25. PubMed ID: 3548637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased platelet monoamine oxidase activity in female anorexia nervosa.
    Díaz-Marsá M; Carrasco JL; Hollander E; César J; Saiz-Ruiz J
    Acta Psychiatr Scand; 2000 Mar; 101(3):226-30. PubMed ID: 10721871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in platelet markers of obsessive-compulsive patients during a double-blind trial of fluvoxamine versus clomipramine.
    Marazziti D; Pfanner C; Palego L; Gemignani A; Milanfranchi A; Ravagli S; Lensi P; Presta S; Cassano GB
    Pharmacopsychiatry; 1997 Nov; 30(6):245-9. PubMed ID: 9442546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder.
    Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L
    Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet serotonergic markers as endophenotypes for obsessive-compulsive disorder.
    Delorme R; Betancur C; Callebert J; Chabane N; Laplanche JL; Mouren-Simeoni MC; Launay JM; Leboyer M
    Neuropsychopharmacology; 2005 Aug; 30(8):1539-47. PubMed ID: 15886722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased platelet monoamine oxidase activity in female bulimia nervosa.
    Carrasco JL; Díaz-Marsá M; Hollander E; César J; Saiz-Ruiz J
    Eur Neuropsychopharmacol; 2000 Mar; 10(2):113-7. PubMed ID: 10706992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet MAO deamination of serotonin in depressed patients. Changes after imipramine treatment and clinical correlations.
    Quintana J
    Biol Psychiatry; 1988 Jan; 23(1):44-52. PubMed ID: 3337854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal assessment of symptom and subtype categories in obsessive-compulsive disorder.
    Besiroglu L; Uguz F; Ozbebit O; Guler O; Cilli AS; Askin R
    Depress Anxiety; 2007; 24(7):461-6. PubMed ID: 17131352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and pharmacogenetic study of glutamate transporter (SLC1A1) in Iranian patients with obsessive-compulsive disorder.
    Abdolhosseinzadeh S; Sina M; Ahmadiani A; Asadi S; Shams J
    J Clin Pharm Ther; 2019 Feb; 44(1):39-48. PubMed ID: 30315580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder.
    Hollander E
    J Clin Psychiatry; 1999; 60 Suppl 15():38-44. PubMed ID: 10418814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impulsivity, hostility and suicidality in patients diagnosed with obsessive compulsive disorder.
    Nagy NE; El-Serafi DM; Elrassas HH; Abdeen MS; Mohamed DA
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):284-292. PubMed ID: 32628055
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs.
    Bismuth-Evenzal Y; Gonopolsky Y; Gurwitz D; Iancu I; Weizman A; Rehavi M
    J Affect Disord; 2012 Jan; 136(1-2):99-103. PubMed ID: 21893349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder.
    Verkes RJ; Van der Mast RC; Kerkhof AJ; Fekkes D; Hengeveld MW; Tuyl JP; Van Kempen GM
    Biol Psychiatry; 1998 May; 43(10):740-6. PubMed ID: 9606528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.